Orchestra BioMed Inc.
OBIO | NASDAQ
$6.25
+$0.17 (+2.80%)
At close: Sep 21, 2026, 4:00 PM ET
$6.35
+$0.10 (+1.60%)
Pre-market:
Sep 22, 2026, 7:47 AM ET
Company Profile
Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo Corporation is dedicated to the development and market introduction of Virtue SAB for artery disease. The company's headquarters are located in New Hope, Pennsylvania.
Key Executives
| Name | Position |
|---|---|
| David Hochman | Founder, Chairman of the Board of Directors & Chief Executive Officer |
| Andrew Lawrence Taylor | Chief Financial Officer |
| Darren R. Sherman | Founder, President, Chief Operating Officer & Director |
| Yuval Hay Mika D.Sc | GM & Chief Technology Officer of Bioelectronic Therapies |
| Avraham Matityahu Fischer | Senior Vice President of Medical Affairs & Innovation |
| Bob Laughner | Senior Vice President of Regulatory & Quality |
| Hans-Peter Stoll | Senior Vice President & Medical Director |
| Juan Lorenzo | Senior Vice President of Product Development |
| Lisa Daniels | Vice President of Human Resources |
| William Reed Little | Executive Vice President of Corporate Development & Strategy |
Orchestra BioMed Inc.
| Country | United States |
| IPO Date | Aug 3, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 86 |
| CEO | David Hochman |
Contact Details
150 Union Square Drive New Hope,
Pennsylvania 18938 United States
Stock Details
| Ticker Symbol | OBIO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001814114 |
| CUSIP Number | 68572M106 |
| ISIN Number | US68572M1062 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove OBIO